For those desiring to outshine the market, the strategic selection of individual stocks is paramount. Well-chosen stocks have the potential to substantially boost your wealth.
As of close of business last night, CytomX Therapeutics Inc’s stock clocked out at $4.07, down -6.86% from its previous closing price of $4.37. In other words, the price has decreased by -$6.86 from its previous closing price. On the day, 4.39 million shares were traded. CTMX stock price reached its highest trading level at $4.49 during the session, while it also had its lowest trading level at $4.07.
Ratios:
To gain a deeper understanding of CTMX’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 1.17 and its Current Ratio is at 1.17.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, Jefferies on May 06, 2024, Upgraded its rating to Buy and sets its target price to $8 from $2.50 previously.
BMO Capital Markets Downgraded its Outperform to Market Perform on November 14, 2022, whereas the target price for the stock was revised from $3 to $2.60.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Mar 19 ’24 when McCarthy Sean A. sold 20,223 shares for $2.09 per share. The transaction valued at 42,175 led to the insider holds 524,481 shares of the business.
BELVIN MARCIA sold 12,795 shares of CTMX for $26,684 on Mar 19 ’24. The SVP, Chief Scientific Officer now owns 168,579 shares after completing the transaction at $2.09 per share. On Mar 19 ’24, another insider, Landau Jeffrey B, who serves as the Chief Business Officer of the company, sold 6,562 shares for $2.09 each. As a result, the insider received 13,685 and left with 110,060 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, CTMX now has a Market Capitalization of 277320032 and an Enterprise Value of 115092152. For the stock, the TTM Price-to-Sale (P/S) ratio is 2.74. Its current Enterprise Value per Revenue stands at 1.137 whereas that against EBITDA is -26.71.
Stock Price History:
Over the past 52 weeks, CTMX has reached a high of $5.85, while it has fallen to a 52-week low of $1.04. The 50-Day Moving Average of the stock is 77.00%, while the 200-Day Moving Average is calculated to be 146.08%.
Shares Statistics:
It appears that CTMX traded 4.78M shares on average per day over the past three months and 24065720 shares per day over the past ten days. A total of 67.31M shares are outstanding, with a floating share count of 66.88M. Insiders hold about 1.84% of the company’s shares, while institutions hold 47.92% stake in the company. Shares short for CTMX as of 1713139200 were 3593963 with a Short Ratio of 0.75, compared to 1710460800 on 3530600. Therefore, it implies a Short% of Shares Outstanding of 3593963 and a Short% of Float of 5.35.
